EurekAlert! -
10 Nov 2014 07:00
(KU Leuven) A new drug combination for rheumatoid arthritis treats the disease just as well as other intensive treatment strategies but with less medication and fewer side effects at a significantly lower cost. Doctoral researcher Diederik De Cock describes the strategy in a new study published in Annals of Rheumatic Diseases.
Share this Article